Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

Condition:   Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Intervention:   Drug: Carbo, 5FU, Cetuximab
Sponsors:   Groupe Oncologie Radiotherapie Tete et Cou;   Gustave Roussy, Cancer Campus, Grand Paris
Recruiting

http://ift.tt/2FlaIvo